Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

COVID-19 Updates:      COVID-19 Resources »      Vaccine Update »      Updated Visitor Policy »      What We're Doing to Keep You Safe »

CAR-T Inquiry

Interested in Chimeric Antigen Receptor Therapy (CAR-T)? Stanford offers CAR-T Therapy for Diffuse Large B-Cell Lymphoma, Acute Lymphoblastic Leukemia, Multiple Myeloma, and Follicular Lymphoma patients. Fill out the required fields and we will follow up in 1-2 business days.

CAR-T Therapy of DLBCL patients at Stanford require:

  • Review of all PETCT images. Scans performed outside Stanford will need to be provided as CD files for review at the time
    of evaluation
  • Lymph node biopsy specimens will require Stanford pathology review. Blocks and slides will be requested for pathology review

Patient Information
 

*
*
*
 

Referring Physician
 

*
*
 
 

Medical History
 

*
*
Invalid Captcha
   

Privacy Statement

We are committed to your privacy. For more details on how your information is collected, stored, and protected, please see our Legal Notices and Privacy Policy.